Mentions
Extended reach
Total likes
Video views
AI synopsis
Several discussions highlight the efficacy of the high-sensitivity cardiac troponin assay, stating it 'can improve patient care' and 'is safe to use,' showcasing excitement and optimism. The tone conveys urgency about integrating this practice into emergency departments, as phrases like 'seems like kind of a big deal' and 'landmark trial' illustrate the high regard and anticipated influence of the findings, suggesting a shift in clinical practice.
Most discussions align positively with the conclusions of the study, highlighting the effectiveness of high-sensitivity cardiac troponin assays.
The significant interest in the topic is reflected in the many comments and shares of related content, indicating relevance to various medical professionals.
While many posts provide supportive sentiments, few dive deeply into the methodology or nuanced implications of the findings, resulting in moderate engagement.
Contributors perceive the study as having a high impact on patient care and emergency medicine practices.
High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster Randomized Controlled Trial | Circulation (1/6) #cardioed #foamed https://t.co/1abio6J7CC
Congratulations to the HiSTORIC @HighSTEACS @atula_tweets investigators for this landmark trial in cardiac biomarker #troponin & implementation science research. The trial https://t.co/TPRbOjgYbC & our editorial https://t.co/ldKsuv9mZZ are available in the latest @CircAHA issue. https://t.co/UG0SBx6aSN
Fresh from @CircAHA https://t.co/2RYbi9nYGH Presentation trop <5 ng/L ➡️earlier but safe discharge of patients in 32000 recruits & 7 hospitals! Great work by @HighSTEACS @chapdoc1 @anoopshah17 @ColinBerryMD #epeeps #cardioed #RadialFirst @mmamas1973 @purviparwani @DrMarthaGulati https://t.co/V3907VYCtX
#CircOnTheRun: This week's join corresponding author, Prof. Nicholas Mills, and Guest Editor, Prof. Allan Jaff, as they discuss The HiSTORIC Trial Listen here: https://t.co/2njdn4A7dv Article: https://t.co/IRZlCfU4hG #AHAJournals @HighSTEACS https://t.co/PkpHoOdsth
#HiSTORIC #RCT: @HighSTEACS early rule-out pathway using hs-cTnI is associated w/ decreased length of stay and hospital admissions in suspected ACS patients, though non-inferiority for safety was not met. @atula_tweets @EdinUniCVS #AHAJournals https://t.co/3zB2L5EOsP https://t.co/sBa8N2D6Xs
High-Sensitivity Cardiac #Troponin on Presentation to Rule Out #MI Circulation RT of @vas’s_vassiliou https://t.co/wCDWPczA4x
In this episode, experts discuss high sensitivity troponin testing and its clinical implications in suspected myocardial infarction. Key topics include limits of detection, the significance of delta troponin results…
This episode of EMplify Conversation features Sam Ashoo MD and TR Eckler MD discussing high-sensitivity troponin testing for evaluating myocardial infarction. The conversation covers assay limits, indeterminate results…
RT @emergmedottawa: EMOttawa JC: High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: RCT @CircAHA https://…
RT @emergmedottawa: EMOttawa JC: High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: RCT @CircAHA https://…
EMOttawa JC: High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: RCT @CircAHA https://t.co/zSTRa8UMmA An early rule-out strategy using hs-cTn is effective at reducing ED LOS (at centres retesting 6/12 hours) for ACS and is safe to use. #FOAMed https://t.co/J56B2RqQXb
@smithECGBlog Hi. There is RCT evidence for using single hstroponin sampling to safely discharge patients with acute chest pain. It requires initial trop<LoD and 2hs of pain. https://t.co/uYUhRBroQ0
Today was a fun day seeing how a new & improved lab test can have amazing results & improve patient care! @Gleason4plus5 & team @stjoes_health labs switched to high sensitivity Troponin yesterday! #labmedicine #pathology https://t.co/jOOtQOvCHg
New2Trip: High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: Stepped-Wedge Cluster Randomized Controlled Trial https://t.co/cWPM14vCyq
New2Trip: High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: Stepped-Wedge Cluster Randomized Controlled Trial https://t.co/cWPM14vCyq
New2Trip: High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: Stepped-Wedge Cluster Randomized Controlled Trial https://t.co/cWPM14vCyq
New2Trip: High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: Stepped-Wedge Cluster Randomized Controlled Trial https://t.co/cWPM14vCyq
EvidenceAlerts | High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster Randomized Controlled Trial. https://t.co/XJlTT4CBeI
High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster Random… https://t.co/iYxYuhj08S
https://t.co/SFo7YZVeSQ
New2Trip: High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: Stepped-Wedge Cluster Randomized Controlled Trial https://t.co/cWPM14vCyq
RT @lucasojesilva12: High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster RCT https…
High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster RCT https://t.co/5woHeWgMzq
High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction A Stepped-Wedge Cluster Randomized Controlled Trial. "We evaluated the efficacy and safety of implementing an early rule-out pathway in 31 492 consecutive patients" https://t.co/knOSAokznS https://t.co/1GLnMKcuIN
RT @CircAHA: #CircOnTheRun: This week's join corresponding author, Prof. Nicholas Mills, and Guest Editor, Prof. Allan Jaff, as they discus…
RT @CircAHA: #CircOnTheRun: This week's join corresponding author, Prof. Nicholas Mills, and Guest Editor, Prof. Allan Jaff, as they discus…
RT @CircAHA: #CircOnTheRun: This week's join corresponding author, Prof. Nicholas Mills, and Guest Editor, Prof. Allan Jaff, as they discus…
RT @CircAHA: #CircOnTheRun: This week's join corresponding author, Prof. Nicholas Mills, and Guest Editor, Prof. Allan Jaff, as they discus…
RT @CircAHA: #CircOnTheRun: This week's join corresponding author, Prof. Nicholas Mills, and Guest Editor, Prof. Allan Jaff, as they discus…
RT @CircAHA: #CircOnTheRun: This week's join corresponding author, Prof. Nicholas Mills, and Guest Editor, Prof. Allan Jaff, as they discus…
#CircOnTheRun: This week's join corresponding author, Prof. Nicholas Mills, and Guest Editor, Prof. Allan Jaff, as they discuss The HiSTORIC Trial Listen here: https://t.co/2njdn4A7dv Article: https://t.co/IRZlCfU4hG #AHAJournals @HighSTEACS https://t.co/PkpHoOdsth
RT @ALEX_MISCHIE: High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster Randomized C…
RT @ALEX_MISCHIE: High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster Randomized C…
RT @yadersandoval: Congratulations to the HiSTORIC @HighSTEACS @atula_tweets investigators for this landmark trial in cardiac biomarker #tr…
RT @yadersandoval: Congratulations to the HiSTORIC @HighSTEACS @atula_tweets investigators for this landmark trial in cardiac biomarker #tr…
RT @CircAHA: #HiSTORIC #RCT: @HighSTEACS early rule-out pathway using hs-cTnI is associated w/ decreased length of stay and hospital admiss…
RT @yadersandoval: Congratulations to the HiSTORIC @HighSTEACS @atula_tweets investigators for this landmark trial in cardiac biomarker #tr…
RT @CircAHA: #HiSTORIC #RCT: @HighSTEACS early rule-out pathway using hs-cTnI is associated w/ decreased length of stay and hospital admiss…
RT @CircAHA: #HiSTORIC #RCT: @HighSTEACS early rule-out pathway using hs-cTnI is associated w/ decreased length of stay and hospital admiss…
RT @yadersandoval: Congratulations to the HiSTORIC @HighSTEACS @atula_tweets investigators for this landmark trial in cardiac biomarker #tr…
RT @CircAHA: #HiSTORIC #RCT: @HighSTEACS early rule-out pathway using hs-cTnI is associated w/ decreased length of stay and hospital admiss…
RT @yadersandoval: Congratulations to the HiSTORIC @HighSTEACS @atula_tweets investigators for this landmark trial in cardiac biomarker #tr…
RT @CircAHA: #HiSTORIC #RCT: @HighSTEACS early rule-out pathway using hs-cTnI is associated w/ decreased length of stay and hospital admiss…
RT @yadersandoval: Congratulations to the HiSTORIC @HighSTEACS @atula_tweets investigators for this landmark trial in cardiac biomarker #tr…
RT @CircAHA: #HiSTORIC #RCT: @HighSTEACS early rule-out pathway using hs-cTnI is associated w/ decreased length of stay and hospital admiss…
RT @CircAHA: #HiSTORIC #RCT: @HighSTEACS early rule-out pathway using hs-cTnI is associated w/ decreased length of stay and hospital admiss…
#HiSTORIC #RCT: @HighSTEACS early rule-out pathway using hs-cTnI is associated w/ decreased length of stay and hospital admissions in suspected ACS patients, though non-inferiority for safety was not met. @atula_tweets @EdinUniCVS #AHAJournals https://t.co/3zB2L5EOsP https://t.co/sBa8N2D6Xs
RT @yadersandoval: Congratulations to the HiSTORIC @HighSTEACS @atula_tweets investigators for this landmark trial in cardiac biomarker #tr…
RT @yadersandoval: Congratulations to the HiSTORIC @HighSTEACS @atula_tweets investigators for this landmark trial in cardiac biomarker #tr…
RT @yadersandoval: Congratulations to the HiSTORIC @HighSTEACS @atula_tweets investigators for this landmark trial in cardiac biomarker #tr…
RT @yadersandoval: Congratulations to the HiSTORIC @HighSTEACS @atula_tweets investigators for this landmark trial in cardiac biomarker #tr…
High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster Randomized Controlled Trial https://t.co/wf1QPcgxRW https://t.co/jJ9yz2Gz59
RT @yadersandoval: Congratulations to the HiSTORIC @HighSTEACS @atula_tweets investigators for this landmark trial in cardiac biomarker #tr…
RT @yadersandoval: Congratulations to the HiSTORIC @HighSTEACS @atula_tweets investigators for this landmark trial in cardiac biomarker #tr…
RT @yadersandoval: Congratulations to the HiSTORIC @HighSTEACS @atula_tweets investigators for this landmark trial in cardiac biomarker #tr…
RT @yadersandoval: Congratulations to the HiSTORIC @HighSTEACS @atula_tweets investigators for this landmark trial in cardiac biomarker #tr…
Congratulations to the HiSTORIC @HighSTEACS @atula_tweets investigators for this landmark trial in cardiac biomarker #troponin & implementation science research. The trial https://t.co/TPRbOjgYbC & our editorial https://t.co/ldKsuv9mZZ are available in the latest @CircAHA issue. https://t.co/UG0SBx6aSN
RT @AndyNeill: I've been out of the ED for 2yrs doing ICU training but this paper on early rule out strategies with undetectable on arrival…
I've been out of the ED for 2yrs doing ICU training but this paper on early rule out strategies with undetectable on arrival seems like kind of a big deal. Is rule out with undetectable on admission an acceptable thing now? https://t.co/55JRlnRezo https://t.co/OLjyp2TiDw
RT @chapdoc1: High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster Randomized Contr…
RT @chapdoc1: High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster Randomized Contr…
RT @chapdoc1: High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster Randomized Contr…
RT @chapdoc1: High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster Randomized Contr…
RT @chapdoc1: High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster Randomized Contr…
RT @chapdoc1: High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster Randomized Contr…
RT @chapdoc1: High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster Randomized Contr…
RT @chapdoc1: High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster Randomized Contr…
RT @chapdoc1: High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster Randomized Contr…
RT @vass_vassiliou: Fresh from @CircAHA https://t.co/2RYbi9nYGH Presentation trop <5 ng/L ➡️earlier but safe discharge of patients in 32000…
RT @SABOURETCardio: High-Sensitivity Cardiac #Troponin on Presentation to Rule Out #MI Circulation RT of @vas’s_vassiliou https://t.co/…
RT @vass_vassiliou: Fresh from @CircAHA https://t.co/2RYbi9nYGH Presentation trop <5 ng/L ➡️earlier but safe discharge of patients in 32000…
RT @vass_vassiliou: Fresh from @CircAHA https://t.co/2RYbi9nYGH Presentation trop <5 ng/L ➡️earlier but safe discharge of patients in 32000…
RT @SABOURETCardio: High-Sensitivity Cardiac #Troponin on Presentation to Rule Out #MI Circulation RT of @vas’s_vassiliou https://t.co/…
High-Sensitivity Cardiac #Troponin on Presentation to Rule Out #MI Circulation RT of @vas’s_vassiliou https://t.co/wCDWPczA4x
RT @vass_vassiliou: Fresh from @CircAHA https://t.co/2RYbi9nYGH Presentation trop <5 ng/L ➡️earlier but safe discharge of patients in 32000…
RT @vass_vassiliou: Fresh from @CircAHA https://t.co/2RYbi9nYGH Presentation trop <5 ng/L ➡️earlier but safe discharge of patients in 32000…
RT @troponinpapers: High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster Randomized…
RT @vass_vassiliou: Fresh from @CircAHA https://t.co/2RYbi9nYGH Presentation trop <5 ng/L ➡️earlier but safe discharge of patients in 32000…
RT @chapdoc1: High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster Randomized Contr…
RT @vass_vassiliou: Fresh from @CircAHA https://t.co/2RYbi9nYGH Presentation trop <5 ng/L ➡️earlier but safe discharge of patients in 32000…
RT @vass_vassiliou: Fresh from @CircAHA https://t.co/2RYbi9nYGH Presentation trop <5 ng/L ➡️earlier but safe discharge of patients in 32000…
RT @vass_vassiliou: Fresh from @CircAHA https://t.co/2RYbi9nYGH Presentation trop <5 ng/L ➡️earlier but safe discharge of patients in 32000…
RT @vass_vassiliou: Fresh from @CircAHA https://t.co/2RYbi9nYGH Presentation trop <5 ng/L ➡️earlier but safe discharge of patients in 32000…
RT @vass_vassiliou: Fresh from @CircAHA https://t.co/2RYbi9nYGH Presentation trop <5 ng/L ➡️earlier but safe discharge of patients in 32000…
RT @vass_vassiliou: Fresh from @CircAHA https://t.co/2RYbi9nYGH Presentation trop <5 ng/L ➡️earlier but safe discharge of patients in 32000…
RT @vass_vassiliou: Fresh from @CircAHA https://t.co/2RYbi9nYGH Presentation trop <5 ng/L ➡️earlier but safe discharge of patients in 32000…
RT @vass_vassiliou: Fresh from @CircAHA https://t.co/2RYbi9nYGH Presentation trop <5 ng/L ➡️earlier but safe discharge of patients in 32000…
RT @vass_vassiliou: Fresh from @CircAHA https://t.co/2RYbi9nYGH Presentation trop <5 ng/L ➡️earlier but safe discharge of patients in 32000…
RT @vass_vassiliou: Fresh from @CircAHA https://t.co/2RYbi9nYGH Presentation trop <5 ng/L ➡️earlier but safe discharge of patients in 32000…
RT @vass_vassiliou: Fresh from @CircAHA https://t.co/2RYbi9nYGH Presentation trop <5 ng/L ➡️earlier but safe discharge of patients in 32000…
Fresh from @CircAHA https://t.co/2RYbi9nYGH Presentation trop <5 ng/L ➡️earlier but safe discharge of patients in 32000 recruits & 7 hospitals! Great work by @HighSTEACS @chapdoc1 @anoopshah17 @ColinBerryMD #epeeps #cardioed #RadialFirst @mmamas1973 @purviparwani @DrMarthaGulati https://t.co/V3907VYCtX
RT @troponinpapers: High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster Randomized…
RT @troponinpapers: High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster Randomized…
RT @troponinpapers: High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster Randomized…
RT @chapdoc1: High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster Randomized Contr…
RT @chapdoc1: High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster Randomized Contr…
RT @chapdoc1: High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster Randomized Contr…
RT @chapdoc1: High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster Randomized Contr…
RT @chapdoc1: High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster Randomized Contr…
RT @chapdoc1: High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster Randomized Contr…
RT @troponinpapers: High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster Randomized…
High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster Randomized Controlled Trial https://t.co/snngWz1BHr https://t.co/wfSd67Qvqk
High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster Randomized Controlled Trial https://t.co/nXoduOSOTA #medtwitter
RT @chapdoc1: High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster Randomized Contr…
RT @ValleAlfonso:
RT @chapdoc1: High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster Randomized Contr…
RT @chapdoc1: High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster Randomized Contr…
RT @chapdoc1: High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster Randomized Contr…
RT @chapdoc1: High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster Randomized Contr…
RT @chapdoc1: High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster Randomized Contr…
RT @chapdoc1: High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster Randomized Contr…
RT @chapdoc1: High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster Randomized Contr…
RT @chapdoc1: High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster Randomized Contr…
RT @chapdoc1: High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster Randomized Contr…
High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster Randomized Controlled Trial | Circulation (1/6) #cardioed #foamed https://t.co/1abio6J7CC
RT @medrxivpreprint: High-sensitivity cardiac troponin on presentation to rule out myocardial infarction: a stepped-wedge cluster randomise…
011 High-sensitivity cardiac troponin on presentation to rule out myocardial infarction (HiSTORIC): a stepped-wedge cluster randomised controlled trial https://t.co/VWCcdhPycf #ambulancejournal rss feeds #feedly
#medical #health #news #information #doctor 011 High-sensitivity cardiac troponin on presentation to rule out myocardial infarction (HiSTORIC): a stepped-wedge cluster randomised controlled trial https://t.co/4BNhJ09D3W
HiSTORIC - High-Sensitivity cardiac Troponin On presentation to Rule out myocardial InfarCtion: A stepped-wedge cluster randomised controlled trial #esccongress19 @escardio @secardiologia @SVCardio